MedPath

Effect of Lavandula Officinalis in treatment of diabetes

Phase 2
Conditions
Diabetes.
Diabetes mellitus
E10-E14
Registration Number
IRCT20200826048534N1
Lead Sponsor
Shahre-kord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Diagnosis of diabetes
Patients aged 30 to 60 years
Fasting blood sugar =126 mg / dl
Intravenous blood serum glucose 200 mg/dl, 2 hours after ingestion of 75 g of oral glucose
Not receiving insulin
HbA1C from 7 to 8.5
Diagnosis of diabetes is less than 10 years
Use only oral antihyperglycemic drugs(Metformin,Glibenclamide)

Exclusion Criteria

Smoking
Chronic Cardiovascular Diseases
Chronic Kidney Disease
Triglycerides more than 500
Pregnancy
Taking Anticoagulants (except Aspirin)
Chronic Liver Diseases except Fatty Liver
Advanced Diabetic Retinopathy
Kidney Failure
Heart Failure
Hemorrhagic Stroke

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath